Data / Form D filings / Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc.: Form D filings
Lyndra Therapeutics, Inc., a biotechnology company in Watertown, MA, filed 8 Form D notices with the SEC between 2016 and 2023. The latest, on December 29, 2023, reports $122.7 million sold of a $206.1 million offering to 16 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 65 GROVE STREET, SUITE 301, Watertown, MA, 02472
- Phone
- (857) 267-5746
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1679037
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 29, 2023 | New notice | $206,055,340 | $122,749,667 | $83,305,673 | 16 | Dec 15, 2023 | sec.gov |
| Jun 7, 2023 | New notice | $179,262,848 | $20,350,715 | $158,912,133 | 7 | May 23, 2023 | sec.gov |
| Jun 23, 2021 | New notice | $65,000,000 | $60,470,112 | $4,529,888 | 22 | Jun 8, 2021 | sec.gov |
| Jan 28, 2019 | New notice | $60,903,006 | $55,243,392 | $5,659,614 | 23 | Jan 11, 2019 | sec.gov |
| Apr 19, 2017 | Amendment | $23,082,575 | $23,082,575 | 15 | Jun 22, 2016 | sec.gov | |
| Mar 7, 2017 | Amendment | $20,082,575 | $20,082,575 | 15 | Jun 22, 2016 | sec.gov | |
| Feb 10, 2017 | Amendment | $17,082,576 | $17,082,576 | 14 | Jun 22, 2016 | sec.gov | |
| Jul 13, 2016 | New notice | $5,932,584 | $5,932,584 | 9 | Jun 22, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Zafi S. Avnur | Director | |
| Ashish S. Singh | Director | |
| Jessica Ballinger | Executive Officer, Director | |
| Robert S. Langer | Director | |
| Doug S. Dachille | Director | |
| Amy Schulman | Director | |
| Patricia S. Hurter | Director | |
| Catherine S. Reynolds | Director | |
| Helene S. Madonick | Director | |
| Carlo Giovanni Traverso | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Dec 25, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Lyndra Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.